Treatment of patients with haemophilia and inhibitory antibodies.

Abstract excerpt

The development of inhibitory antibodies is a complication which arise in approximately 10% of patients with haemophilia A. The underlying genetic mutation is the single most important predisposing cause, although other risk factors have been identified. Periodic screening for inhibitors is a vit...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Blood Coagulation Factors
• Share to Child, Preschool
• Share to Blood Coagulation Factor Inhibitors